N,N'-Carbonyldiimidazole (CDI) market demonstrates steady expansion, with its valuation reaching USD 43 million in 2023 and projected to grow at a CAGR of 5.20% , reaching approximately USD 67.86 million by 2032 . This growth trajectory reflects increasing adoption in pharmaceutical and agrochemical applications, particularly in developing economies where API...
